Literature DB >> 10024189

Respiratory symptoms and long-term risk of death from cardiovascular disease, cancer and other causes in Swedish men.

A Rosengren1, L Wilhelmsen.   

Abstract

BACKGROUND: Depressed respiratory function and respiratory symptoms are associated with impaired survival. The present study was undertaken to assess the relation between respiratory symptoms and mortality from cardiovascular causes, cancer and all causes in a large population of middle-aged men.
METHODS: Prospective population study of 6442 men aged 51-59 at baseline, free of clinical angina pectoris and prior myocardial infarction.
RESULTS: During 16 years there were 1804 deaths (786 from cardiovascular disease, 608 from cancer, 103 from pulmonary disease and 307 from any other cause). Men with effort-related breathlessness had increased risk of dying from all of the examined diseases. After adjustment for age, smoking habit and other risk factors, the relative risk (RR) associated with breathlessness of dying from coronary disease was 1.43 (95% CI : 1.16-1.77), from stroke 1.77 (95% CI: 1.07-2.93), from any cardiovascular disease 1.48 (95% CI : 1.24-1.76), cancer 1.36 (95% CI : 1.11-1.67) and from any cause 1.62 (95% CI: 1.44-1.81). An independent effect of breathlessness on cardiovascular death, cancer death and mortality from all causes was found in life-time non-smokers, and also if men with chest pain not considered to be angina were excluded. An independent effect was also found if all deaths during the first half of the follow-up were excluded. Men with cough and phlegm, without breathlessness, also had an elevated risk of dying from cardiovascular disease and cancer, but after adjustment for smoking and other risk factors this was no longer significant. However, a slightly elevated independent risk of dying from any cause was found (RR = 1.18 [95% CI: 1.02-1.36]).
CONCLUSION: A positive response to a simple question about effort related breathlessness predicted subsequent mortality from several causes during a follow-up period of 16 years, independently of smoking and other risk factors.

Entities:  

Keywords:  Biology; Cancer; Cardiovascular Effects; Causes Of Death--men; Demographic Factors; Developed Countries; Diseases; Europe; Mortality; Neoplasms; Northern Europe; Physiology; Population; Population Dynamics; Pulmonary Effects; Respiratory Insufficiency; Risk Factors; Scandinavia; Sweden

Mesh:

Year:  1998        PMID: 10024189     DOI: 10.1093/ije/27.6.962

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia.

Authors:  A Frostad; V Soyseth; T Haldorsen; A Andersen; A Gulsvik
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

2.  Respiratory symptoms and cardiovascular causes of deaths: A population-based study with 45 years of follow-up.

Authors:  Knut Stavem; Henrik Schirmer; Amund Gulsvik
Journal:  PLoS One       Date:  2022-10-20       Impact factor: 3.752

3.  Dyspnoea as a predictor of cause-specific heart/lung disease mortality in Bangladesh: a prospective cohort study.

Authors:  Gene R Pesola; Maria Argos; Vernon M Chinchilli; Yu Chen; Faruque Parvez; Tariqul Islam; Alauddin Ahmed; Rabiul Hasan; Muhammad Rakibuz-Zaman; Habibul Ahsan
Journal:  J Epidemiol Community Health       Date:  2016-01-14       Impact factor: 3.710

4.  Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/Vlaardingen study.

Authors:  Sylwia M Figarska; H Marike Boezen; Judith M Vonk
Journal:  Eur J Epidemiol       Date:  2012-10-07       Impact factor: 8.082

5.  The association between symptoms and exposure is stronger in dropouts than in non-dropouts among employees in Norwegian smelters: a five-year follow-up study.

Authors:  Vidar Søyseth; Helle Laier Johnsen; Merete Drevvatne Bugge; Johny Kongerud
Journal:  Int Arch Occup Environ Health       Date:  2011-03-29       Impact factor: 3.015

Review 6.  Treatment efficacy for non-cardiovascular chest pain: a systematic review and meta-analysis.

Authors:  Jakob M Burgstaller; Boris F Jenni; Johann Steurer; Ulrike Held; Maria M Wertli
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

7.  Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Mario Santos; Dalane W Kitzman; Kunihiro Matsushita; Laura Loehr; Carla A Sueta; Amil M Shah
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

8.  Respiratory symptoms and respiratory deaths: A multi-cohort study with 45 years observation time.

Authors:  Knut Stavem; Ane Johannessen; Rune Nielsen; Amund Gulsvik
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.